Health inspection·August 1, 2019

F 0758 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on review of medical record, review of hospital records, staff interview, and review of facility policy, the facility failed to ensure a resident had a supporting diagnosis for use of an antipsychotic medication. This affected one resident (#102) of five residents reviewed for unnecessary medications. The facility census was 118. Findings include: Review of medical record revealed Resident #102 was admitted to the facility on [DATE]. Diagnoses included anoxic brain damage, other symbolic dysfunctions, type two diabetes with neuropathy, other specified anxiety disorders, major depressive disorder, and vascular dementia with behavioral disturbance. Review of Resident #102's hospital record dated 06/07/19 through 06/14/19 revealed no evidence the resident had a diagnosis of bipolar disorder. Review of comprehensive assessment dated [DATE] revealed the resident was rarely or never understood and the mental status interview was not conducted. The resident did not have indicators of potential psychosis and did not exhibit behavioral symptoms. Review of current physician orders on 07/31/19 revealed Resident #102 had an order for Zyprexa (an antipsychotic medication) 2.5 milligrams (mg) daily for bipolar disorder. There was no evidence the resident had a diagnosis of bipolar disorder. Review of physician progress notes for Resident #102, dated 06/21/19, 06/27/19, 07/08/19, and 07/12/19, revealed no evidence the resident had a diagnosis of bipolar disorder. Interview on 08/01/19 at 9:24 A.M., with the Director of Nursing (DON) verified Resident #102 did not have a diagnosis of bipolar disorders for the use of Zyprexa. Review of facility policy titled Psychotropic Medications, dated 04/09/19 revealed no medications were to be used for off label purposes; they must be used for their intent and purpose. Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 3 Event ID: 365416 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 365416 B. Wing A. Building (X3) DATE SURVEY COMPLETED 08/01/2019 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Ohio Living Westminster-Thurber 717 Neil Avenue Columbus, OH 43215 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)